Whitehawk Therapeutics (WHWK) Operating Leases (2019 - 2024)
Whitehawk Therapeutics' (WHWK) quarterly Operating Leases came in at $565000.0 in Q4 2024, down 32.17% year-on-year from $833000.0 in Q1 2024, and down 9.46% on a QoQ basis from $624000.0 in Q3 2024.
Whitehawk Therapeutics (WHWK) Operating Leases (2019 - 2024) Analysis & Trends
Whitehawk Therapeutics (WHWK) has 6 years of Operating Leases data on file, last reported at $565000.0 in Q4 2024.
- On a quarterly basis, Operating Leases fell 32.17% year-over-year to $565000.0 in Q4 2024; TTM through Dec 2024 was $565000.0, a 32.17% decrease from a year earlier, with the FY2024 full-year figure at $565000.0, down 32.17% from the prior year.
- Operating Leases for Q4 2024 stood at $565000.0, down from $624000.0 in the prior quarter.
- Over the last five years, Operating Leases for WHWK reached as high as $1.7 million in Q3 2022 and fell as low as $9955.0 in Q2 2020.
- Historically, Operating Leases has averaged $858882.9 across 5 years, with a median of $757500.0 in 2023.
- Across the five-year window, Operating Leases tumbled 96.54% in 2020 and soared 250.42% in 2022, its largest moves.
- Year by year, Operating Leases stood at $9955.0 in 2020, then soared by 4661.43% to $474000.0 in 2021, then surged by 250.42% to $1.7 million in 2022, then sank by 49.85% to $833000.0 in 2023, then sank by 32.17% to $565000.0 in 2024.
- Per Business Quant data, the three most recent Operating Leases figures were $565000.0 in Q4 2024, $624000.0 in Q3 2024, and $682000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Whitehawk Therapeutics | 34.18 Mn | 34.18 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 565,000.00 |
| Sep 30, 2024 | 624,000.00 |
| Jun 30, 2024 | 682,000.00 |
| Mar 31, 2024 | 1.16 Mn |
| Dec 31, 2023 | 833,000.00 |
| Sep 30, 2023 | 946,000.00 |
| Jun 30, 2023 | 1.47 Mn |
| Mar 31, 2023 | 1.16 Mn |
| Dec 31, 2022 | 1.66 Mn |
| Sep 30, 2022 | 1.72 Mn |
| Jun 30, 2022 | 1.44 Mn |
| Mar 31, 2022 | 424,000.00 |
| Dec 31, 2021 | 474,000.00 |
| Sep 30, 2021 | 523,000.00 |
| Jun 30, 2020 | 9,955.00 |
| Mar 31, 2020 | 39,171.00 |
| Dec 31, 2019 | 67,438.00 |
| Sep 30, 2019 | 236,223.00 |
| Jun 30, 2019 | 288,055.00 |
| Mar 31, 2019 | 337,737.00 |